Substituted phenoxy N-alkylated thiazoledinedione as estrogen related receptor-alpha modulators

Details for Australian Patent Application No. 2008222749 (hide)

Owner Jassen Pharmaceutica NV

Inventors Searle, Lily Lee; Gaul, Michael; Rentzeperis, Dionisios

Agent Shelston IP

Pub. Number AU-A-2008222749

PCT Pub. Number WO2008/109731

Priority 60/893,458 07.03.07 US

Filing date 6 March 2008

Wipo publication date 12 September 2008

International Classifications

C07D 277/34 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 5/32 (2006.01) Drugs for disorders of the endocrine system

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/109731 Priority application(s): WO2008/109731

29 September 2011 Alteration of Name

  The name of the applicant has been altered to Janssen Pharmaceutica N.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008222753-O6-alkylguanine-DNA alkyltransferase inactivators

2008222747-Lock lever mounting bracket for headrails on coverings for architectural openings